Pulmonx (LUNG) Non-Current Deferred Tax Liability (2019 - 2025)
Historic Non-Current Deferred Tax Liability for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $47000.0.
- Pulmonx's Non-Current Deferred Tax Liability fell 6356.59% to $47000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $47000.0, marking a year-over-year decrease of 6356.59%. This contributed to the annual value of $87000.0 for FY2024, which is 9322.43% down from last year.
- Pulmonx's Non-Current Deferred Tax Liability amounted to $47000.0 in Q3 2025, which was down 6356.59% from $41000.0 recorded in Q2 2025.
- In the past 5 years, Pulmonx's Non-Current Deferred Tax Liability registered a high of $1.3 million during Q4 2023, and its lowest value of $37000.0 during Q4 2021.
- Over the past 5 years, Pulmonx's median Non-Current Deferred Tax Liability value was $71000.0 (recorded in 2021), while the average stood at $141105.3.
- In the last 5 years, Pulmonx's Non-Current Deferred Tax Liability soared by 126595.74% in 2023 and then crashed by 9322.43% in 2024.
- Pulmonx's Non-Current Deferred Tax Liability (Quarter) stood at $37000.0 in 2021, then surged by 154.05% to $94000.0 in 2022, then skyrocketed by 1265.96% to $1.3 million in 2023, then tumbled by 93.22% to $87000.0 in 2024, then plummeted by 45.98% to $47000.0 in 2025.
- Its Non-Current Deferred Tax Liability stands at $47000.0 for Q3 2025, versus $41000.0 for Q2 2025 and $79000.0 for Q1 2025.